EFFICIENCY OF WHITE CELL FILTRATION AND A FREEZE-THAW PROCEDURE FOR REMOVAL OF HIV-INFECTED CELLS FROM BLOOD

被引:23
作者
BRUISTEN, SM
TERSMETTE, M
WESTER, MR
VOS, AHV
KOPPELMAN, MHGM
HUISMAN, JG
机构
[1] Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Department of Developmental Research, Amsterdam, 1066 CX, F117
关键词
D O I
10.1046/j.1537-2995.1990.30991048791.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Strategies for diminishing the risk of blood transfusion‐associated transmission of HIV‐1 were evaluated. HIV‐1‐infected peripheral blood mononuclear cells were added to blood that was subsequently filtered by using different white cell (WBC) filters (cellulose acetate and polyester). The average log reduction of infected cells with polyester filters was at least 2.5 as measured by ID50 titration and polymerase chain reaction. In two WBC filtration experiments with blood from seropositive donors diluted 1:4 with seronegative blood, log reductions of 2.4 and greater than 2.5 were observed. No cell‐free virus was retained by the filter used. A freeze‐thaw procedure applied to HIV‐1‐ contaminated blood resulted in a minimal log reduction. These results indicate that the reduction of HIV‐1 infectivity as a result of filtration is mainly due to the removal of HIV‐1‐infected WBCs, and that complete removal of infected WBCs cannot be achieved by the current filtration or freeze‐thaw procedures. However, the development of filters with enhanced ability to remove (possibly infected) WBCs may have the added benefit of improving the safety of donor blood, especially in multiply transfused patients. 1990 AABB
引用
收藏
页码:833 / 837
页数:5
相关论文
共 25 条
[1]  
ALTER HJ, 1988, VIRAL HEPATITIS LIVE, P537
[2]   EXPOSURE OF PATIENTS TO HUMAN IMMUNODEFICIENCY VIRUS THROUGH THE TRANSFUSION OF BLOOD COMPONENTS THAT TEST ANTIBODY-NEGATIVE [J].
CUMMING, PD ;
WALLACE, EL ;
SCHORR, JB ;
DODD, RY .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (14) :941-946
[3]  
DERONDE A, 1988, LANCET, V2, P574
[4]  
GERMENIS A, 1989, ACTA HAEMATOL-BASEL, V82, P57
[5]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625
[6]   PREVENTION OF TRANSMISSION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) THROUGH TRANSFUSION, BY DONOR SCREENING WITH ANTIBODY TO THE VIRUS - ONE-YEAR EXPERIENCE [J].
INABA, S ;
SATO, H ;
OKOCHI, K ;
FUKADA, K ;
TAKAKURA, F ;
TOKUNAGA, K ;
KIYOKAWA, H ;
MAEDA, Y .
TRANSFUSION, 1989, 29 (01) :7-11
[7]   ESTIMATING THE INCUBATION-TIME DISTRIBUTION AND EXPECTED NUMBER OF CASES OF TRANSFUSION-ASSOCIATED ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
KALBFLEISCH, JD ;
LAWLESS, JF .
TRANSFUSION, 1989, 29 (08) :672-676
[8]   EVALUATION OF 3 2ND-GENERATION AND 3 CONFIRMATORY ASSAYS FOR ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS [J].
LELIE, PN ;
REESINK, HW ;
HUISMAN, H .
VOX SANGUINIS, 1988, 54 (02) :84-91
[9]  
LOVRIC VA, 1989, LANCET, V1, P71
[10]  
Maniatis T., 1982, MOL CLONING